• LAST PRICE
    0.7612
  • TODAY'S CHANGE (%)
    Trending Up0.0012 (0.1579%)
  • Bid / Lots
    0.7413/ 12
  • Ask / Lots
    0.7779/ 2
  • Open / Previous Close
    0.7612 / 0.7600
  • Day Range
    Low 0.7395
    High 0.7924
  • 52 Week Range
    Low 0.5800
    High 5.9000
  • Volume
    541,449
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.76
TimeVolumeALVR
09:32 ET11970.79242
09:38 ET1000.761
09:45 ET8000.771886
09:48 ET1000.765
09:50 ET1000.765
09:52 ET3000.7723
09:54 ET2000.765
09:56 ET71000.7795
09:57 ET51000.7551
10:01 ET1000.76
10:03 ET1000.76
10:08 ET3600.7795
10:12 ET2000.76
10:15 ET1000.76
10:19 ET1000.76
10:24 ET2000.76
10:26 ET2000.76975
10:35 ET2000.76
10:39 ET2000.76
10:42 ET2290.7601
10:46 ET1000.76
10:50 ET1000.76
10:53 ET1000.76
10:55 ET104500.7651
10:57 ET1000.76
11:08 ET2000.7672
11:11 ET2000.76
11:18 ET1000.76
11:22 ET1000.76
11:27 ET2000.76
11:29 ET3000.76585
11:33 ET1000.76
11:49 ET1000.7601
11:51 ET6400.771
11:58 ET53000.76
12:02 ET1000.7551
12:03 ET2000.7551
12:05 ET17280.75815
12:07 ET3000.7611
12:18 ET1790.7583
12:27 ET3320.7552
12:34 ET1000.7552
12:39 ET1000.7552
12:43 ET3000.7552
12:50 ET1000.7552
12:56 ET1000.7552
01:01 ET2000.761
01:03 ET2320.7611
01:10 ET594640.74999
01:14 ET95380.75
01:17 ET232920.7409
01:19 ET62000.74
01:21 ET198000.74
01:24 ET265440.7445
01:26 ET335780.743
01:28 ET323000.743
01:30 ET2081000.74505
01:32 ET101000.7451
01:33 ET32000.75
01:37 ET4000.7566
01:39 ET1000.7566
01:48 ET1000.75
01:51 ET2000.7562
02:00 ET2270.75
02:02 ET2000.75
02:04 ET7160.75
02:06 ET1000.75
02:08 ET10450.75
02:09 ET3000.75
02:11 ET1000.75
02:13 ET3000.75
02:15 ET3000.75
02:18 ET1000.75
02:20 ET1000.75
02:22 ET1000.75
02:26 ET2630.7405
02:27 ET3000.7475
02:29 ET1550.7406
02:31 ET4000.7405
02:33 ET4320.7405
02:40 ET2000.741
02:42 ET1000.741
02:44 ET3000.741
02:45 ET3000.7411
02:47 ET1000.7542
02:51 ET2000.7411
02:54 ET1000.74775
02:56 ET2000.7411
02:58 ET10000.74775
03:02 ET4000.7411
03:03 ET2040.7411
03:05 ET2000.7542
03:07 ET11000.7412
03:09 ET1000.7412
03:12 ET2000.7478
03:16 ET3000.7412
03:18 ET40840.7478
03:20 ET1000.7542
03:21 ET2000.7412
03:23 ET3000.7478
03:27 ET8270.75
03:30 ET3000.7511
03:32 ET8000.7547
03:34 ET4830.7544
03:36 ET14010.756
03:38 ET56860.756
03:39 ET6000.75605
03:41 ET18710.756
03:43 ET2000.756
03:45 ET9520.7599
03:48 ET15970.76
03:50 ET1000.76
03:52 ET6000.75992
03:54 ET3000.76
03:57 ET2210.76
03:59 ET21080.7612
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesALVR
Allovir Inc
87.5M
-0.5x
---
United StatesVSTM
Verastem Inc
87.9M
-0.8x
---
United StatesCGTX
Cognition Therapeutics Inc
86.9M
-2.4x
---
United StatesCNTB
Connect Biopharma Holdings Ltd
88.2M
-1.5x
---
United StatesSLS
Sellas Life Sciences Group Inc
86.6M
-1.3x
---
United StatesIOBT
IO Biotech Inc
86.3M
-0.7x
---
As of 2024-06-15

Company Information

AlloVir, Inc. is an allogeneic T cell immunotherapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company’s proprietary technology platforms leverage off-the-shelf, allogeneic, single- and multi-virus-specific T cells for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. Its technology and manufacturing process enable the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. Its lead product candidate, posoleucel, is a multi-VST therapy that targets six viruses: adenovirus (BKV), cytomegalovirus (EBV), human herpesvirus 6 (HHV-6) and JC virus (JCV). Its proprietary VST manufacturing platform enables the rapid, robust and reproducible generation of single-virus and multi-virus specific cell therapeutic candidates for clinical use.

Contact Information

Headquarters
1100 Winter StreetWALTHAM, MA, United States 02451
Phone
617-433-2605
Fax
302-655-5049

Executives

Executive Chairman of the Board
David Hallal
President, Chief Financial Officer, Director
Vikas Sinha
Chief Executive Officer, Director
Diana Brainard
Co-Founder, Chief Scientific Officer
Ann Leen
Chief Accounting Officer
Brett Hagen

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$87.5M
Revenue (TTM)
$0.00
Shares Outstanding
115.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.78
EPS
$-1.65
Book Value
$1.28
P/E Ratio
-0.5x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.